Old Web
English
Sign In
Acemap
>
authorDetail
>
A. Vernaglia Lombardi
A. Vernaglia Lombardi
University of Naples Federico II
Medicine
Chemotherapy
Pathology
Ovarian cancer
Carboplatin
4
Papers
43
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Carboplatin plus paclitaxel versus carboplatin plus Stealth liposomal doxorubicin in patients with advanced ovarian cancer (AOC): Preliminary activity results of the MITO-2 randomized multicenter trial
2016
Journal of Clinical Oncology
S Pignata
Giovanni Scambia
Antonella Savarese
Enrico Breda
Roberto Sorio
A. Vernaglia Lombardi
Vittorio Gebbia
Paolo Scollo
Domenica Lorusso
Alessandro Morabito
Show All
Source
Cite
Save
Citations (5)
Carboplatin and Pegylated Liposomal Doxorubicin for Advanced Ovarian Cancer: Preliminary Activity Results of the MITO-2 Phase III Trial
2009
Oncology
S. Pignata
Giovanni Scambia
Antonella Savarese
Enrico Breda
Roberto Sorio
C. Pisano
Domenica Lorusso
Francesco Cognetti
A. Vernaglia Lombardi
Vittorio Gebbia
Paolo Scollo
Alessandro Morabito
Giuseppe Signoriello
Federica Perrone
Show All
Source
Cite
Save
Citations (28)
Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study.
2002
Oncology
Chiara Carlomagno
Rossella Lauria
M. De Laurentiis
Grazia Arpino
Erminia Massarelli
C. Ferrara
A. Milano
A. Vernaglia Lombardi
R. Costanzo
Giuseppe Catalano
Angelo Raffaele Bianco
S. De Placido
Show All
Source
Cite
Save
Citations (2)
Vinorelbine + Mitomycin C as Second-Line Treatment of Metastatic Breast Cancer: A Two-Stage Phase 2 Study
2000
Oncology
S. De Placido
Rossella Lauria
F. Perrone
A. Vernaglia Lombardi
Chiara Carlomagno
Elisa Varriale
R. Costanzo
L. Leo
M. De Laurentiis
A. R. Bianco
Show All
Source
Cite
Save
Citations (8)
1